NEFROTIK
PADA ANAK
Edema anasarka
Hiperlipidemia
Pathogenesis of nephrotic syndrome
Maintain
DAMAGED barrier
Proteinuria
function
Filtration route
Restriction Electrostatic
Molecules > 10 kDa ( negative charge)
Disfunction
Non selective Selective
proteinuria proteinuria
Haycock G. The child with idiopathic nephrotic syndrome. In: Postlethwaite R, editor. Clinical
paediatric nephrology. 3rd edition. Baltimore: Oxford University Press;2003. p. 344-7.
Sindrom Nefrotik
ETIOLOGI
Diopatik (SNI) 90%
Kongenital ( 0-3 bulan)
Sekunder : mengikuti penyakit sistemik
Sindrom Nefrotik
SN BAWAAN
Finnish type
Jarang
Plasenta besar
Autosomal resesif
Edema masa neonatus sampai 3 bulan
Mutasi gen NPHS1, lokasi pada kromosom 19q13.1
Resisten obat
SN SEKUNDER
Penyakit metabolik : Diabetes, amiloidosis
Penyakit infeksi : Malaria, hepatitis B, sistosoma
Toksin dan alergen : Logam berat, gigitan serangga
Penyakit sistemik : SLE, PHS, poliarteritis
Neoplasma : Hodgkin, tumor paru
Sindrom Nefrotik
BATASAN
Remisi: proteinuria (-) / trace 3 hari
berturut-turut (1 minggu)
Relaps: proteinuria > +2 dlm 3 hari
berturut-turut (1 minggu)
Relaps jarang : Relaps < 2x/6 bulan
pertama setelah respon awal atau <
4x/tahun pengamatan
Relaps sering : Relaps > 2x/6 bulan
pertama setelah respon awal atau >
4x/tahun pengamatan
Sindrom Nefrotik
BATASAN
Dependen steroid: Relaps 2x berurutan
saat dosis steroid diturunkan atau 14 hr
terapi dihentikan
Resisten steroid : tidak terjadi remisi pada
terapi prednison full dose 4 minggu
Sensitif steroid : Remisi terjadi pada
pemberian prednison full dose dalam 4
minggu
Sindrom Nefrotik
KOMPLIKASI
Komplikasi Mayor
Infeksi
Hipovolemia
Trombosis
GGA
Hiperlipidemia
Malnutrisi
Loss of transport protein (transferrin, Hormone-
binding protein)
Efek samping pengobatan
Steroid
Alkylating agent
Cyclosporin, etc
Sindrom Nefrotik
KONDISI YANG BERHUBUNGAN DENGAN SN
Alergi
Jamur
Susu sapi
Sengatan lebah
House dust
Obat-obatan
AINS
Ampisilin
Merkuri
Keganasan
Penyakit Hodgkin dan Non Hodgkin’s lymphoma
Colon and bronchogenic carcinoma
Lain-lain
Infeksi virus
DM
Imunisasi
Edema anasarka
Ascites
Pretibial edema
Genital edema
Gambaran Histopatologi Sindrom
Nefrotik pada Anak
ISKDC Noer MS Steroid
Gambaran Histopatologi 1981 1997 Responsif
(N=471) (n=71) (%) ISKDC
Kelainan minimal (KM) 363 (77%) 59 (83.1%) 93.1
Normal
MCNS
Shows no staining with antisera specific for IgG, IgA, IgM, C3, C4, or C1q. Absence of humoral
components of the immune system
There are occasional specimens that will have small amounts of exclusively mesangial
immunoglobulin (especially IgM) or complement accumulation that can still be designated minimal
change glomerulopathy. A little bit of mesangial IgM and/or C3 without ultrastructural evidence for
electron dense deposits is tolerable for a diagnosis of minimal change glomerulopathy.
Well defined mesangial electron dense deposits, however, worsen the prognosis for response to
steroids or spontaneous remission. Thus, if there are electron dense deposits, minimal change
glomerulopathy is not an appropriate diagnoses.
Electron Microscopy
Characteristic histologic finding in MCD is diffuse effacement of the epithelial ceel foot proces on EM.
A finding also observed with FGS
Electron micrograph in minimal change disease showing a normal glomerular basement membrane
(GBM), no immune deposits, and the characteristic widespread fusion of the epithelial cell foot
processes (arrows). Courtesy of Helmut Rennke, MD.
Histopathologic diagnosis of the NS
Histopathologic diagnosis of the NS
MGN by Light has a thickening of the capillary wall, sort of referred to as menbrane
of the capillary. Its parodoxical, you would think w/ thicker membrane, you should
have less protein getting across. But the fact is there more proteinuria, b/s abnormal
permeability. Even though the basementmembrane is thicker, it’s more permeable.
Histopathologic diagnosis of the NS
Benign looking on Light, capillaries are open, but appears thickened. This is immune-
complex mediated dz. Immune-complex deposit along the capillary loops. By IF, we can
see very bright staining that is indicating the location of immune complex
MANAGEMENT OF NEPHROTIC
SYNDROME
1. Drugs
o Steroid
o Non-steroid
o Adjunctive therapy
Levamisole
2. Supportive treatment
3. Management of complications
STANDARS TREATMENT OF NS
CORTICOSTEROID (PREDNISON)
INITIAL
FULL DOSE ALTERNATING DOSE
4 WEEKS 4 WEEKS
Prednison FD: 60 mg/m2/day
Prednison AD: 40 mg/m2/day
STEROID RESISTANT
IMMUNOSUPPRESIVE AGENTS
Steroid Resistant Nephrotic Syndrome
Cyclophosphamide
Oral: 2-3 mg/kg/day, divided dose
For 8 -12 weeks
Pulse:
500-750 mg/m2 BSA diluted in 250 ml NaCl
0.9% in 2 hours
Prerequisite:
Hb > 8 g/dL; Leucocyte >5,000/L;
platelet >100,000/L
Contraindication of Steroid/ Toxic
steroid
Contraindication steroid:
Severe hypertension
Renal failure
Severe infection CPA oral or pulse
Diabetes mellitus, etc Others:
Chlorambucil
Toxic steroid Cyclosporin
Severe hypertension
Massive striae
Cataract. etc
STEROID RESISTANT NEPHROTIC SYNDROME
80
60
Median time to
40
response = 10 days
20
0
1 2 3 4 5 6 7 8
Week of response
Outcome at 1 year in children with
Steroid sensitive NS
Steroid
dependent No relapse
17% 21%
Frequent
relapse 22%
40% Infrequent
relapse
Adulthood relapser
Cases to be referred
Resistant steroid
Infantile NS
Hypocomplementemia persistent
Mixed nephrotic dan nephritic
Severe complications
Dependent steroid, frequent relapses
THANK YOU !